Chondroitin Export Market Intelligence: India's 71 Suppliers Shipping to 70 Countries — TransData Nexus 2026

Q: Who are the top chondroitin exporters from India?

The top chondroitin exporters from India are: 1. PANACEA BIOTEC PHARMA LIMITED — $874.4K (17.2% market share); 2. MEDINOMICS HEALTH CARE PRIVATE LIMITED — $848.3K (16.7% market share); 3. TROIKAA PHARMACEUTICALS LIMITED — $573.8K (11.3% market share); 4. AUROLAB — $421.0K (8.3% market share); 5. ORGANOSYN LIFE SCIENCES PRIVATE LIMITED — $419.3K (8.2% market share). Together they account for 61.7% of India's total chondroitin export value.

Q: What is the total export value of chondroitin from India?

The total export value of chondroitin from India is $5.1M USD, recorded across 349 shipment transactions from 71 active exporters to 70 destination countries. The average shipment value is $14.6K.

Q: Which countries import chondroitin from India?

India exports chondroitin to 70 countries worldwide. The top importing countries are: RUSSIA (22.5% share, $1.1M), NIGERIA (21.6% share, $1.1M), FRANCE (19.4% share, $984.5K), UKRAINE (8.2% share, $417.9K), UNITED ARAB EMIRATES (4.1% share, $209.5K). These five markets account for 75.8% of total export value.

Q: What is the HS code for chondroitin exports from India?

The primary HS code for chondroitin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of chondroitin exports from India?

The average unit price for chondroitin exports from India is $10.06 USD per unit, with prices ranging from $0.01 to $699.75 depending on formulation, packaging, and order volume. The total market is valued at $5.1M across 349 shipments.

Q: Which ports handle chondroitin exports from India?

The primary ports for chondroitin exports from India are CHENNAI AIR (11.5% of shipments), DELHI AIR (8.0% of shipments), BANGALORE ACC (INBLR4) (7.2% of shipments), SAHAR AIR (6.0% of shipments), SAHAR AIR CARGO ACC (INBOM4) (5.2% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of chondroitin?

India is one of the world's leading exporters of chondroitin due to its large base of 71 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports chondroitin to 70 countries, demonstrating 36% global market coverage.

Q: What certifications do Indian chondroitin exporters need?

Indian chondroitin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import chondroitin from India?

There are 136 registered buyers importing chondroitin from India, spread across 70 countries. The repeat buyer rate is 45.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top chondroitin supplier from India?

PANACEA BIOTEC PHARMA LIMITED is the leading chondroitin exporter from India with a market share of 17.2% and total export value of $874.4K across 16 shipments. The top 5 suppliers together control 61.7% of total export value.

Suresh Sormare

Chondroitin

India Pharmaceutical Trade Intelligence

$5.1M71 Suppliers70 CountriesHS 30049099

ExportsIndia → RUSSIA22.5%India → NIGERIA21.6%

ImportsCHINA → India$2.1M UNITED STATES → India$27.4K

#1 Supplier: PANACEA BIOTEC #1 Buyer: FIDSON HEALTHCARE

Chondroitin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Chondroitin to the World

Between 2022 and 2026, India exported $5.1M worth of chondroitin across 349 verified shipments to 70 countries — covering 36% of world markets in the Nutritional Supplements segment. The largest destination is RUSSIA (22.5%). PANACEA BIOTEC PHARMA LIMITED leads with a 17.2% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Chondroitin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Chondroitin export data snapshot — $5.1M · 71 exporters · 70 countriesTransData Nexus · Indian Customs Data

Top Chondroitin Exporters from India

71 active exporters · Ranked by export value

View all 71 →

Top Chondroitin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	PANACEA BIOTEC PHARMA LIMITED	$874.4K	16	1	17.2%
2	MEDINOMICS HEALTH CARE PRIVATE LIMITED

Top Countries Importing Chondroitin from India

70 destination markets · Ranked by import value

All 70 countries →

Top Countries Importing Chondroitin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	RUSSIA	$1.1M	22.5%
2	NIGERIA	$1.1M	21.6%
3	FRANCE	$984.5K	19.4%
4	UKRAINE	$417.9K	8.2%
5	UNITED ARAB EMIRATES	$209.5K	4.1%
6	SRI LANKA	$166.4K	3.3%
7	MALDIVES	$131.3K	2.6%
8	HONDURAS	$108.7K	2.1%
9	SOUTH AFRICA	$100.0K	2.0%
10	GHANA	$97.1K	1.9%

RUSSIA is India's largest chondroitin export destination, absorbing 22.5% of total exports worth $1.1M. The top 5 importing countries — RUSSIA, NIGERIA, FRANCE, UKRAINE, UNITED ARAB EMIRATES — together account for 75.8% of India's total chondroitin export value. The remaining 65 destination countries collectively receive the other 24.2%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Chondroitin to India?

3 origin countries · Total import value: $2.1M

India imports chondroitin from 3 countries with a combined import value of $2.1M. The largest supplier is CHINA ($2.1M, 26 shipments), followed by UNITED STATES and GERMANY. All values are from Indian Customs (DGFT) import records.

Countries Supplying Chondroitin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	CHINA	$2.1M	26	98.7%
2	UNITED STATES	$27.4K	6	1.3%
3	GERMANY	$430	1	0.0%

CHINA is the largest supplier of chondroitin to India, accounting for 98.7% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Chondroitin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, chondroitin sulfate is predominantly marketed as a dietary supplement and is not subject to the same rigorous approval processes as pharmaceutical drugs. Consequently, there are no approved Abbreviated New Drug Applications (ANDAs) for chondroitin sulfate listed in the FDA's Orange Book. This classification allows for a more streamlined regulatory pathway for Indian exporters aiming to enter the U.S. market. However, compliance with the Dietary Supplement Health and Education Act (DSHEA) of 1994 is mandatory, necessitating adherence to Good Manufacturing Practices (GMP) and accurate labeling standards.

The absence of import alerts or significant regulatory actions against chondroitin sulfate products underscores a stable regulatory environment. Given the 71 active Indian exporters, the U.S. market presents a viable opportunity for expansion, provided that exporters maintain stringent quality control measures and comply with FDA regulations.

2EU & UK Regulatory Framework

Within the European Union and the United Kingdom, chondroitin sulfate is also primarily marketed as a dietary supplement. As such, it does not require marketing authorization from the European Medicines Agency (EMA) or the UK's Medicines and Healthcare products Regulatory Agency (MHRA). Nevertheless, compliance with EU Directive 2002/46/EC on food supplements is essential, which includes adherence to safety, labeling, and composition standards.

Manufacturers exporting to these regions must ensure that their production facilities meet the EU's Good Manufacturing Practice (GMP) requirements, as outlined in EudraLex Volume 4. This compliance is critical to facilitate market entry and maintain consumer trust.

3WHO Essential Medicines & Global Standards

Chondroitin sulfate is not listed in the World Health Organization's (WHO) Model List of Essential Medicines, indicating its classification as a non-essential medicine. Consequently, it is not subject to the WHO Prequalification Programme. However, adherence to international pharmacopoeia standards, such as those set forth in the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), is crucial. These standards ensure product quality and consistency, which are vital for market acceptance and regulatory compliance.

4India Regulatory Classification

In India, chondroitin sulfate is classified as a dietary supplement and is not listed under Schedules H, H1, or X of the Drugs and Cosmetics Act, indicating it is available over the counter (OTC). As such, it is not subject to price control measures by the National Pharmaceutical Pricing Authority (NPPA) and does not have a ceiling price under the Drug Price Control Order (DPCO). For export purposes, obtaining a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) is typically required, ensuring compliance with export regulations.

5Patent & Exclusivity Status

Chondroitin sulfate is a well-established compound with no active patents or exclusivity rights, allowing for robust generic competition. This status enables multiple manufacturers to produce and export the compound without infringement concerns, fostering a competitive market environment.

6Recent Industry Developments

In February 2025, the Government Chemist published a critical review titled "Chondroitin Sulfate: A Critical Review of Generic and Specific Problems in Its Characterization and Determination." This review addresses challenges in the authentication of chondroitin-containing supplements, highlighting the need for stringent quality control measures to prevent adulteration and ensure product integrity. (gov.uk)

In November 2025, the UK's Food Standards Agency (FSA) implemented the Genetic Technology (Precision Breeding) Regulations 2025, allowing businesses to apply for Precision Bred Organism (PBO) food and feed marketing authorizations. While this regulation primarily pertains to genetically modified organisms, it underscores the evolving regulatory landscape for food and dietary supplements, potentially impacting future classifications and requirements for products like chondroitin sulfate. (food.gov.uk)

These developments emphasize the importance of continuous monitoring of regulatory changes and adherence to quality standards to maintain market access and consumer trust.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Supply Chain Risk Assessment — Chondroitin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of chondroitin, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 60–70% of India's API and KSM requirements are sourced from China, underscoring a significant dependency. This reliance exposes the supply chain to vulnerabilities, particularly when Chinese manufacturers face operational disruptions due to environmental regulations or other factors. For instance, in July 2018, shutdowns of Chinese chemical plants led to increased prices and supply constraints for Indian pharmaceutical companies.

To mitigate this dependency, the Indian government has initiated the Production Linked Incentive (PLI) scheme, aiming to bolster domestic production of critical APIs and KSMs. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and Clavulanic Acid, marking a significant step toward reducing import reliance. However, the effectiveness of these initiatives in addressing the broader dependency on Chinese imports remains to be fully realized.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters of chondroitin from India account for 61.7% of the total export value, with PANACEA BIOTEC PHARMA LIMITED leading at a 17.2% share. This concentration suggests a moderate risk, as disruptions affecting these key suppliers could significantly impact the global chondroitin supply chain. While the PLI scheme aims to diversify and strengthen domestic manufacturing capabilities, its current focus on specific APIs and KSMs may not directly address the supply chain risks associated with chondroitin.

Access Complete Chondroitin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 349 transactions across 70 markets.

Request Demo View Pricing

Frequently Asked Questions — Chondroitin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top chondroitin exporters from India?

The leading chondroitin exporters from India are PANACEA BIOTEC PHARMA LIMITED, MEDINOMICS HEALTH CARE PRIVATE LIMITED, TROIKAA PHARMACEUTICALS LIMITED, and 11 others. PANACEA BIOTEC PHARMA LIMITED leads with 17.2% market share ($874.4K). The top 5 suppliers together control 61.7% of total export value.

What is the total export value of chondroitin from India?

The total export value of chondroitin from India is $5.1M, recorded across 349 shipments from 71 active exporters to 70 countries. The average shipment value is $14.6K.

Which countries import chondroitin from India?

India exports chondroitin to 70 countries. The top importing countries are RUSSIA (22.5%), NIGERIA (21.6%), FRANCE (19.4%), UKRAINE (8.2%), UNITED ARAB EMIRATES (4.1%), which together account for 75.8% of total export value.

What is the HS code for chondroitin exports from India?

The primary HS code for chondroitin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Chondroitin

Chondroitin

How India Exports Chondroitin to the World

Top Chondroitin Exporters from India

Top Countries Importing Chondroitin from India

Who Supplies Chondroitin to India?

Quick Facts

Related Nutritional Supplements

Related Analysis

Need Details?

Regulatory Landscape — Chondroitin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Supply Chain Risk Assessment — Chondroitin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Chondroitin Trade Intelligence

Frequently Asked Questions — Chondroitin Exports from India

Who are the top chondroitin exporters from India?

What is the total export value of chondroitin from India?

Which countries import chondroitin from India?

What is the HS code for chondroitin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of chondroitin exports from India?

Which ports handle chondroitin exports from India?

Why is India a leading exporter of chondroitin?

What certifications do Indian chondroitin exporters need?

How many buyers import chondroitin from India?

What is the market share of the top chondroitin exporter from India?

Analysis Methodology